These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38319866)

  • 1. A Randomized Trial of PHOTOdynamic Surgery in Non-Muscle-Invasive Bladder Cancer.
    Heer R; Lewis R; Vadiveloo T; Yu G; Mariappan P; Cresswell J; McGrath J; Nabi G; Mostafid H; Lazarowicz H; Kelly J; Duncan A; Penegar S; Breckons M; Wilson L; Clark E; Feber A; Orozco-Leal G; Tandogdu Z; Taylor E; N'Dow J; Norrie J; Ramsay C; Rice S; Vale L; MacLennan G; Hall E
    NEJM Evid; 2022 Oct; 1(10):EVIDoa2200092. PubMed ID: 38319866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic Diagnosis-guided Transurethral Resection of Bladder Tumour in Participants with a First Suspected Diagnosis of Intermediate- or High-risk Non-muscle-invasive Bladder Cancer: Cost-effectiveness Analysis Alongside a Randomised Controlled Trial.
    Yu G; Rice S; Heer R; Lewis R; Vadiveloo T; Mariappan P; Penegar S; Clark E; Tandogdu Z; Hall E; Vale L
    Eur Urol Open Sci; 2023 Jul; 53():67-77. PubMed ID: 37441343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic versus white-light-guided resection of first-diagnosis non-muscle-invasive bladder cancer: PHOTO RCT.
    Heer R; Lewis R; Duncan A; Penegar S; Vadiveloo T; Clark E; Yu G; Mariappan P; Cresswell J; McGrath J; N'Dow J; Nabi G; Mostafid H; Kelly J; Ramsay C; Lazarowicz H; Allan A; Breckons M; Campbell K; Campbell L; Feber A; McDonald A; Norrie J; Orozco-Leal G; Rice S; Tandogdu Z; Taylor E; Wilson L; Vale L; MacLennan G; Hall E
    Health Technol Assess; 2022 Oct; 26(40):1-144. PubMed ID: 36300825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic diagnosis-assisted transurethral resection of bladder tumor for high-risk non-muscle invasive bladder cancer improves intravesical recurrence-free survival (BRIGHT study).
    Kawai T; Matsuyama H; Kobayashi K; Ikeda A; Miyake M; Nishimoto K; Matsushita Y; Nishiyama H; Fujimoto K; Oyama M; Miyake H; Azuma H; Inoue K; Mitsui T; Kawakita M; Oyama C; Mizokami A; Abe T; Kuroiwa H; Kume H
    Int J Urol; 2024 Aug; 31(8):906-912. PubMed ID: 38695571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risks and benefits of transurethral resection of the bladder tumor using photodynamic diagnosis with oral 5-aminolevulinic acid hydrochloride according to age and history of recurrence in patients with non-muscle invasive bladder cancer.
    Kobayashi K; Matsuyama H; Oka S; Nakamura K; Misumi T; Hiroyoshi T; Ito H; Isoyama N; Hirata H; Matsumoto H; Shiraishi K
    Photodiagnosis Photodyn Ther; 2023 Mar; 41():103294. PubMed ID: 36681259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact on Japanese healthcare economics of photodynamic diagnosis-assisted transurethral resection of bladder tumor for non-muscle invasive bladder cancer: A multicenter retrospective cohort study.
    Nishimura N; Miyake M; Nakahama T; Miyamoto T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsumoto H; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2023 Dec; 30(12):1112-1119. PubMed ID: 37605814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in oncological benefits from second transurethral resection between white-light initial surgery and photodynamic diagnosis-guided initial surgery for primary high-risk non-muscle invasive bladder cancer.
    Miyake M; Nishimura N; Nakahama T; Nishimoto K; Oyama M; Matsushita Y; Miyake H; Fukuhara H; Inoue K; Kobayashi K; Matsuyama H; Fujii T; Hirao Y; Fujimoto K
    Int J Urol; 2024 Aug; 31(8):876-885. PubMed ID: 38687165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Real-life experience': recurrence rate at 3 years with Hexvix
    Gallagher KM; Gray K; Anderson CH; Lee H; Stewart S; Donat R; Mariappan P
    World J Urol; 2017 Dec; 35(12):1871-1877. PubMed ID: 28803385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative assessment of disease recurrence after transurethral resection of non-muscle-invasive bladder cancer with and without a photodynamic diagnosis using 5-aminolevulinic acid: a propensity score-matching analysis.
    Matsushita Y; Miyake M; Nishimura N; Nishimoto K; Fukuhara H; Kobayashi K; Oyama M; Inoue K; Matsuyama H; Fujimoto K; Miyake H
    Int J Clin Oncol; 2024 Feb; 29(2):205-212. PubMed ID: 38112832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (2nd report): Reduced bladder recurrence after PDD-TURBT.
    Fukuhara H; Yamamoto S; Lai HW; Karashima T; Kurabayashi A; Furihata M; Inoue K
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102757. PubMed ID: 35151889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world experience with 5-aminolevulinic acid for photodynamic diagnosis of bladder cancer (3rd report): Cost impact of transurethral resection of bladder tumor in Japan.
    Fukuhara H; Hagiwara Y; Oba K; Inoue K
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103758. PubMed ID: 37604217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic versus white light-guided treatment of non-muscle invasive bladder cancer: a study protocol for a randomised trial of clinical and cost-effectiveness.
    Tandogdu Z; Lewis R; Duncan A; Penegar S; McDonald A; Vale L; Shen J; Kelly JD; Pickard R; N Dow J; Ramsay C; Mostafid H; Mariappan P; Nabi G; Creswell J; Lazarowicz H; McGrath J; Taylor E; Clark E; Maclennan G; Norrie J; Hall E; Heer R;
    BMJ Open; 2019 Sep; 9(9):e022268. PubMed ID: 31481549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective randomized trial of hexylaminolevulinate photodynamic-assisted transurethral resection of bladder tumour (TURBT) plus single-shot intravesical mitomycin C vs conventional white-light TURBT plus mitomycin C in newly presenting non-muscle-invasive bladder cancer.
    O'Brien T; Ray E; Chatterton K; Khan MS; Chandra A; Thomas K
    BJU Int; 2013 Dec; 112(8):1096-104. PubMed ID: 24053153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(12):1-123. PubMed ID: 34484486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to Turn on the Blue Lights: A Systematic Review and Meta-analysis of Photodynamic Diagnosis for Bladder Cancer.
    Veeratterapillay R; Gravestock P; Nambiar A; Gupta A; Aboumarzouk O; Rai B; Vale L; Heer R
    Eur Urol Open Sci; 2021 Sep; 31():17-27. PubMed ID: 34467237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical BCG therapy with photodynamic diagnosis-guided transurethral resection of bladder tumors improves recurrence-free survival.
    Nakagawa R; Nohara T; Naito R; Kadomoto S; Iwamoto H; Yaegashi H; Kawaguchi S; Shigehara K; Izumi K; Kadono Y; Mizokami A
    Photodiagnosis Photodyn Ther; 2023 Jun; 42():103574. PubMed ID: 37080348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent cystoscopy-assisted en bloc transurethral resection versus conventional transurethral resection in patients with non-muscle invasive bladder cancer: study protocol of a prospective, open-label, randomized control trial (the FLEBER study).
    Miyake M; Nishimura N; Inoue T; Suzuki S; Fujii T; Owari T; Hori S; Nakai Y; Toritsuka M; Nakagawa H; Tsukamoto S; Anai S; Torimoto K; Yoneda T; Tanaka N; Fujimoto K
    Trials; 2021 Feb; 22(1):136. PubMed ID: 33579327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic Diagnosis-Assisted Transurethral Resection Using Oral 5-Aminolevulinic Acid Decreases the Risk of Repeated Recurrence in Non-Muscle-Invasive Bladder Cancer: A Cumulative Incidence Analysis by the Person-Time Method.
    Miyake M; Nishimura N; Nakai Y; Fujii T; Owari T; Hori S; Morizawa Y; Gotoh D; Anai S; Torimoto K; Tanaka N; Hirao Y; Fujimoto K
    Diagnostics (Basel); 2021 Jan; 11(2):. PubMed ID: 33525423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Clinical Research Office of the Endourological Society (CROES) Multicentre Randomised Trial of Narrow Band Imaging-Assisted Transurethral Resection of Bladder Tumour (TURBT) Versus Conventional White Light Imaging-Assisted TURBT in Primary Non-Muscle-invasive Bladder Cancer Patients: Trial Protocol and 1-year Results.
    Naito S; Algaba F; Babjuk M; Bryan RT; Sun YH; Valiquette L; de la Rosette J;
    Eur Urol; 2016 Sep; 70(3):506-15. PubMed ID: 27117749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.